期刊文献+

甲状腺乳头状癌术后刺激状态Tg与颈部淋巴结转移关系的研究 被引量:3

The correlation between the stimulated thyroglobulin level after surgery in papillary thyroid carci- noma and cervical lymph node metastasis
原文传递
导出
摘要 目的探讨甲状腺乳头状癌(PTC)患者术后刺激状态甲状腺球蛋白(Vg)与颈部淋巴结转移的关系。方法45例PTC患者行甲状腺全切或近全切并行颈部淋巴结清扫术,根据是否存在淋巴结转移分为L1和L02组,检测术后刺激状态Tg水平,采用统计学软件对数据进行t检验及相关性分析。结果2组患者的年龄(t=-0.675,P〉0.05)、性别(X^2=1.20,P〉0.05)差异无统计学意义,术后刺激状态Tg水平差异有统计学意义(t=4.167,P〈0.01)。L1组术后刺激状态Tg水平与颈部淋巴结转移水平呈正相关(r=0.676,P〈0.01)。结论PTC患者术后刺激状态Tg水平与颈部淋巴结转移关系密切,是评价PTC术后13^I治疗疗效及判断预后的重要指标。 Objective To discuss the correlation between the stimulated thyroglobulin (Tg) level after surgery in papillary thyroid carcinoma (PTC) and cervical lymph node metastasis. Methods Total thyroidectomy or subtotal thyroidectomy and radical cervical lymphadenectomy have been performed in 45 cases with PTC. All patients have been divided into two groups (L1 group and L0 group) according to whether lymph node metastasis exists. The stimulated Tg level after surgery were mesured and analyzed by t test with statistical software. Results There was no significant difference between the two groups in age (t=-0.675, P〉0.05 ) and gender 0(2= 1.20, P〉0.05 ), but significant difference could be found in stimulated Tg level after surgery between the two groups (t=4.167, P〈0.01 ). There was positive correlation between the stimu- latied Tg level after surgery and cervical lymph node metastasis in Ll group (r=0.676, P〈0.01 ). Conclusion The stimulated Tg level after surgery is closely correlated to cervical lymph node metastasis in patients with PTC, which can be used as an assessment of the effect of the postsurgica113^I therapy and prognosis.
出处 《国际放射医学核医学杂志》 2013年第1期27-29,共3页 International Journal of Radiation Medicine and Nuclear Medicine
关键词 甲状腺肿瘤 乳头状 甲状腺球蛋白 淋巴结 Thyroid neoplasms Carcinoma, papillary Thyroglobulin Lymph nodes
  • 相关文献

参考文献10

  • 1American Thyroid Association (ATA)Guidelines Taskfouce on Thyroid Nodules and Differentiated Thyroid Cancer,Cooper DS,Doherty GM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J].Thyroid:Official Journal of the American Thyroid Association,2009,(l 1):1167-1214.
  • 2Kim TY,Kim WB,Kim ES. Serum thyroglobbulin levels at the time of 131Ⅰ remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma[J].Journal of Clinical Endocrinology and Metabolism,2005,(03):1440-1445.
  • 3Heemstra KA,Liu YY,Stokkel M. Serum thyroglobulin concentrations perdict disease-free remission and death in differentiated thyroid carcinoma[J].Clinical Endocrinology(Oxford),2007,(01):58-64.
  • 4Suh I,Vrients MR,Guerrero MA. Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthlecell neoplasms of the thyroid[J].American Journal of Surgery,2010,(01):41-46.
  • 5高再荣,常伟,崔坤炜,曹卫,曹国祥,黄代娟,张永学.甲状腺乳头状癌术后刺激状态Tg预测^131I清甲治疗后Tg水平的价值[J].中华核医学杂志,2009,29(3):156-159. 被引量:20
  • 6李田军,林岩松,梁军,李小毅,邱李恒,王莎莎,陈永辉,康增寿,李方.^131I治疗前刺激性Tg对乳头状甲状腺癌远处转移的预测价值[J].中华核医学与分子影像杂志,2012,32(3):189-191. 被引量:48
  • 7Lundgren CI,Hall P,Dickman PW. Clinically significant prognostic factors for differentiated thyoid carcinoma:a populationbased,nested case-control study[J].Cancer,2006,(03):524-531.
  • 8Bilimoria KY,Bentrem DJ,Ko CY. Extent of surgery affects survival for papillary thyroid cancer[J].Annals of Surgery,2007,(03):375-384.
  • 9Sawka AM,Orlov S,Gelberg J. Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well-differentiated thyroid carcinoma[J].Head & Neck,2008,(06):693-700.
  • 10Low TH,Delbridge L,Sidhu S. Lymph node status influences follow-up thyroglobulin levels in papillary thyroid cancer[J].Annals of Surgical Oncology,2008,(10):2827-2832.

二级参考文献20

  • 1Toubeau M,Touzery C,Arveux P,et al.Predictive value for disease progression of serum thyrogiohulin levels measured in the postoperative period and after 131^I ablation therapy in patients with differentiated thyroid cancer.J Nucl Med,2004,45:988-994.
  • 2Bemier MO,Morel O,Bodien P,et al.Prognostic value of an increase in the serum thyroglobulin level at the time of the first ablative radioiodine treatment in patients with differentiated thyroid cancer.Eur J Nucl Med Mol Imaging,2005,32:1418-1421.
  • 3Kim TY,Kim WB,Kim ES,et al.Serum thyroglobulin levels at the time of 131Ⅰ remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with well-differentiated thyroid carcinoma.J Clin Endocrinol Metab,2005,90:1440-1445.
  • 4Heemstra KA,Liu YY,Stokkel M,et al.Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma.Clin Endocrinol (Oxf),2007,66:58-64.
  • 5Cooper DS,Doherty GM,Haagen BR,et al.Management guidelines for patients with thyroid nodules and differentiated thyroid cancr:the American Thyroid Association Guidelines Taskforce.Thyroid,2006,16:109-142.
  • 6Pelizzo MR,Merante Boschin I,Toniato A,et al.Diagnosis,treatment,prognostic factors and long-term outcome in papillary thyroid carcinoma.Minerva Eedocrinol,2008,33:359-379.
  • 7Lundgren C,Hall P,Dickman P,et al.Clinically significant pingnostie factors for differentiated thyroid carcinoma:a populationbased,nested case-control study.Cancer,2006,106:524-531.
  • 8Bilimoria K,Bentrem D,Ko C,et al.Extent of surgery affects survival for papillary thyroid cancer.Ann Surg,2007,246:375-384.
  • 9Sawka AM,Orlov S,Gelberg J,et al.Prognostic value of poatsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well-differentiated thyroid carcinoma.Head Neck,2008,30:693-700.
  • 10Low TH,Delbridge L,Sidhu S,et al.Lymph node status influences follow-up thyroglobulin levels in papillary thyroid cancer.Ann Surg Oncol,2008,15:2827-2832.

共引文献62

同被引文献33

  • 1唐伟松.甲状腺癌诊治有待提高的几个方面[J].中国普外基础与临床杂志,2006,13(3):247-249. 被引量:14
  • 2李玉姝,单忠艳,关海霞,金迎,滕晓春,胡凤楠,杨帆,于晓会,范晨玲,李晨阳,滕卫平.甲状腺过氧化物酶抗体和甲状腺球蛋白抗体阳性临界值的确定及其临床意义[J].中华检验医学杂志,2006,29(9):780-783. 被引量:49
  • 3Carling T,Carty SE,Ciarleglio MM,et al.American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma[J].Thyroid,2012,22(3):237-244.
  • 4Ma C,Kuang A,Xie J,et al.Possible explanation for patient’s with discordant findings of serum thymoglobulin and 131I whole body scanning[J].J Nucl Med,2006,47(3):552-553.
  • 5Hjiyiannakis P,Mundy J,Harmer C.Thyroglobulin antibodies in differen-tiated thyroid cancer[J].Clin Oncol(R Coll Radiol),1999,11(4):240-244.
  • 6Mazzaferri EL,Robbins RJ,Spencer CA,et al.A consensus report of the role of serum thyroglobulin as a monitoring method for lowrisk patients with papillary thyroid carcinoma[J].J Clin Endocrinol Metab,2003,88(1):1433-1441.
  • 7Koyno Y,Taruani G.Monoclonal antibodies to thyroglobulin elucidate differences in proteins tructure of thyroglobulinin healthy individuals and those with papillary adenocarcinoma[J].J Clin Endocrinol Metab,1988,61(2):343.
  • 8Demers LM,Spencer CA.Laboratory Medicine Practice Guidelines:Laboratory Support forthe Diagnosis and Monitoring of Thyroid Disease[J].Thyroid,2006,13(1):57-67.
  • 9Pacini F,Capezzone M,Elisei R,et al.Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectablestimulated serum Tg levels after initial treatment[J].J Clin Endocrinol Metab,2002,87(4):1499-1501.
  • 10Pacini F,Molinaro E,Lippi F,et al.Prediction of disease status by recombinant human TSHstimulated serum Tg in the postsurgical follow-up of differentiatedthyroid carcinoma[J].J Clin Endocrinol Metab,2001,86(12):5686-5690.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部